Daiichi Sankyo Company, Limited (Daiichi Sankyo) announced that its generics subsidiary, Daiichi Sankyo Espha, is launching fourteen new generic drugs with six new active ingredients on December 11, as well as two new generic drugs with one new active ingredient in March 2016.